Vertex’s New Cystic Fibrosis Drug Treats the Cause, Not Just the Symptoms
by Melly Alazraki on Feb.24, 2011, under Towing
Vertex Pharmaceutical shares soared 15% Wednesday as Wall Street cheered the results of a late-stage study of its new cystic fibrosis drug, an experimental treatment that targets the underlying cause of the disease rather than just its symptoms.
Continue reading Vertex’s New Cystic Fibrosis Drug Treats the Cause, Not Just the Symptoms
Vertex’s New Cystic Fibrosis Drug Treats the Cause, Not Just the Symptoms originally appeared on DailyFinance on Thu, 24 Feb 2011 12:45:00.
Filed Under: Health Care



